Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

BACKGROUND: Achievement of low-density lipoprotein cholesterol (LDL-C) goal is the most important for the patients with atherosclerotic cardiovascular diseases (ASCVD) who received lipid-lowering therapy. It is unclear that whether combination of ezetimibe with statin is superior to double-dose of s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lipids Health Dis
Main Authors: Wu, Na-Qiong, Guo, Yuan-Lin, Zhu, Cheng-Gang, Gao, Ying, Zhao, Xi, Sun, Di, Sun, Jing, Xu, Rui-Xia, Liu, Geng, Dong, Qian, Li, Jian-Jun
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260646/
https://ncbi.nlm.nih.gov/pubmed/30470229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-018-0909-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares